Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayanthi S Lea

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Molecular Cancer Research : MCR|May 3, 2022
Combinatorial Treatment with PARP-1 Inhibitors and Cisplatin Attenuates Cervical Cancer Growth through Fos-Driven Changes in Gene ExpressionRebecca Gupte, Ken Y Lin, Tulip Nandu, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|November 7, 2009
Secondary cytoreductive surgery for recurrent platinum-sensitive ovarian cancerJohn O Schorge, Shana N Wingo, Rafia Bhore, et al.
Gynecologic Oncology Reports|July 22, 2022
<i>Clostridium</i> and <i>Bacteroides</i> bacteremia as initial presentation of uterine carcinosarcomaChinonye S Imo, Alexandra Spirtos, Yevgenia Fomina, et al.
Gynecologic Oncology|January 29, 2002
Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissectionJayanthi S Lea, Ellen E Sheets, Linda R Duska, et al.
Gynecologic Oncology Reports|September 17, 2020
Current practice patterns in nodal evaluation and adjuvant treatment of advanced stage endometrioid endometrial cancer: An SGO surveyJessica E Parker, David S Miller, Jessica Lee, et al.
American Journal of Clinical Oncology|February 23, 2017
Third-line Salvage Chemotherapy for Recurrent Carcinoma of the Cervix is Associated With Minimal Response Rate and High ToxicityDustin B Manders, Siobhan M Kehoe, David S Miller, et al.
Journal of Cancer Survivorship : Research and Practice|July 17, 2020
The impact of intimate partner violence on breast and cervical cancer survivors in an integrated, safety-net settingKatelyn K Jetelina, Christian Carr, Caitlin C Murphy, et al.
Gynecologic Oncology Reports|August 15, 2020
Practice patterns using minimally invasive surgery for the treatment of ovarian cancer: A survey of physician members of the Society of Gynecologic OncologistsKevin M Kremer, Jessica Lee, Matthew J Carlson, et al.
Gynecologic Oncology|May 20, 2014
Malignant ovarian germ cell tumor - role of surgical staging and gonadal dysgenesisKen Y Lin, Stefanie Bryant, David S Miller, et al.
Gynecologic Oncology|May 2, 2016
Factors influencing primary treatment of midline vulvar cancersLesley B Conrad, Steven A Conrad, David S Miller, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Molecular Cancer Research : MCR|May 3, 2022
Combinatorial Treatment with PARP-1 Inhibitors and Cisplatin Attenuates Cervical Cancer Growth through Fos-Driven Changes in Gene ExpressionRebecca Gupte, Ken Y Lin, Tulip Nandu, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|November 7, 2009
Secondary cytoreductive surgery for recurrent platinum-sensitive ovarian cancerJohn O Schorge, Shana N Wingo, Rafia Bhore, et al.
Gynecologic Oncology Reports|July 22, 2022
<i>Clostridium</i> and <i>Bacteroides</i> bacteremia as initial presentation of uterine carcinosarcomaChinonye S Imo, Alexandra Spirtos, Yevgenia Fomina, et al.
Gynecologic Oncology|January 29, 2002
Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissectionJayanthi S Lea, Ellen E Sheets, Linda R Duska, et al.
Gynecologic Oncology Reports|September 17, 2020
Current practice patterns in nodal evaluation and adjuvant treatment of advanced stage endometrioid endometrial cancer: An SGO surveyJessica E Parker, David S Miller, Jessica Lee, et al.
American Journal of Clinical Oncology|February 23, 2017
Third-line Salvage Chemotherapy for Recurrent Carcinoma of the Cervix is Associated With Minimal Response Rate and High ToxicityDustin B Manders, Siobhan M Kehoe, David S Miller, et al.
Journal of Cancer Survivorship : Research and Practice|July 17, 2020
The impact of intimate partner violence on breast and cervical cancer survivors in an integrated, safety-net settingKatelyn K Jetelina, Christian Carr, Caitlin C Murphy, et al.
Gynecologic Oncology Reports|August 15, 2020
Practice patterns using minimally invasive surgery for the treatment of ovarian cancer: A survey of physician members of the Society of Gynecologic OncologistsKevin M Kremer, Jessica Lee, Matthew J Carlson, et al.
Gynecologic Oncology|May 20, 2014
Malignant ovarian germ cell tumor - role of surgical staging and gonadal dysgenesisKen Y Lin, Stefanie Bryant, David S Miller, et al.
Gynecologic Oncology|May 2, 2016
Factors influencing primary treatment of midline vulvar cancersLesley B Conrad, Steven A Conrad, David S Miller, et al.
Pageof 6